These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 7670404

  • 1. Characterization of late and early hematopoietic progenitor/stem cell sensitivity to mafosfamide.
    Douay L, Giarratana MC, Labopin M, Bardinet D, Bouchet S, Gorin NC.
    Bone Marrow Transplant; 1995 May; 15(5):769-75. PubMed ID: 7670404
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C, Mangoni L, Almici C, Caramatti C, Rizzoli V.
    Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
    [Abstract] [Full Text] [Related]

  • 4. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM, Tafuri A, Fortuna A, Catani L, Rondelli D, Ratta M, Tura S.
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [Abstract] [Full Text] [Related]

  • 5. Plasma interacts with mafosfamide toxicity to normal haematopoietic progenitor cells: impact on in vitro marrow purging.
    Giarratana MC, Gorin NC, Douay L.
    Nouv Rev Fr Hematol (1978); 1995 Dec; 37(2):125-30. PubMed ID: 7644349
    [Abstract] [Full Text] [Related]

  • 6. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM, Fogli M, Fortuna A, Motta MR, Rizzi S, Benini C, Tura S.
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [Abstract] [Full Text] [Related]

  • 8. In vivo effects of GM-CSF and IL-3 on hematopoietic cell recovery in bone marrow and blood after autologous transplantation with mafosfamide-purged marrow in lymphoid malignancies.
    Albin N, Douay L, Fouillard L, Laporte JP, Isnard F, Lesage S, Ozsahin H, Bardinet D, Najman A, Gorin NC.
    Bone Marrow Transplant; 1994 Aug; 14(2):253-9. PubMed ID: 7994241
    [Abstract] [Full Text] [Related]

  • 9. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM, Gulati SC.
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. II. The influence of lymphokines on CFU-GM colonies from human untreated, ASTA-Z or Campath-1M treated bone marrow.
    Mumcuoglu M, Naparstek E, Slavin S.
    Bone Marrow Transplant; 1990 Mar; 5(3):153-8. PubMed ID: 2184907
    [Abstract] [Full Text] [Related]

  • 12. Flt 3 ligand, MGDF, Epo and G-CSF enhance ex vivo expansion of hematopoietic cell compartments in the presence of SCF, IL-3 and IL-6.
    Kobari L, Giarratana MC, Poloni A, Firat H, Labopin M, Gorin NC, Douay L.
    Bone Marrow Transplant; 1998 Apr; 21(8):759-67. PubMed ID: 9603398
    [Abstract] [Full Text] [Related]

  • 13. The synthetic tetrapeptide AcSDKP protects cells that reconstitute long-term bone marrow stromal cultures from the effects of mafosfamide (Asta Z 7654).
    Genevay MC, Mormont C, Thomas F, Berthier R.
    Exp Hematol; 1996 Jan; 24(1):77-81. PubMed ID: 8536796
    [Abstract] [Full Text] [Related]

  • 14. 5-fluorouracil permits access to a primitive subpopulation of peripheral blood stem cells.
    Rice A, Barbot C, Lacombe F, Dubosc-Marchenay N, Marit G, Hau F, Boiron JM, Reiffers J.
    Stem Cells; 1993 Jul; 11(4):326-35. PubMed ID: 8401256
    [Abstract] [Full Text] [Related]

  • 15. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
    Cardier JE, Erickson-Miller CL, Murphy MJ.
    Stem Cells; 1997 Jul; 15(4):286-90. PubMed ID: 9253112
    [Abstract] [Full Text] [Related]

  • 16. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
    Ratajczak MZ, Ratajczak J, Kuczynski W, Light B, Lusk EJ, Gewirtz AM.
    Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
    [Abstract] [Full Text] [Related]

  • 17. The potential role of FLT3 ligand in progenitor and primitive hematopoietic cell expansion.
    Poloni A, Douay L, Giarratana MC, Kobari L, Gorin NC, Olivieri A, Leoni P.
    Boll Soc Ital Biol Sper; 1997 Dec; 73(3-4):55-62. PubMed ID: 9540233
    [Abstract] [Full Text] [Related]

  • 18. Efficacious but insidious: a retrospective analysis of fludarabine-induced myelotoxicity using long-term culture-initiating cells in 100 follicular lymphoma patients.
    Janikova A, Koristek Z, Vinklarkova J, Pavlik T, Sticha M, Navratil M, Kral Z, Vasova I, Mayer J.
    Exp Hematol; 2009 Nov; 37(11):1266-73. PubMed ID: 19654036
    [Abstract] [Full Text] [Related]

  • 19. Cumulative chemotherapy increases mafosfamide toxicity for normal progenitor cells in AML patients: rationale for cryopreserving adapted-dose purged marrow early in first complete remission.
    Martin H, Bruecher J, Claudé R, Hoelzer D.
    Bone Marrow Transplant; 1993 Nov; 12(5):495-9. PubMed ID: 8298560
    [Abstract] [Full Text] [Related]

  • 20. In vitro growth of mobilized peripheral blood progenitor cells is significantly enhanced by stem cell factor.
    Cesana C, Carlo-Stella C, Mangoni L, Regazzi E, Garau D, Sammarelli G, Caramatti C, Almici C, Rizzoli V.
    Stem Cells; 1997 Nov; 15(3):207-13. PubMed ID: 9170212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.